Nestle Sues RenaGum Maker Over Kidney Disease Treatment
According to Nestle's complaint, Mastix's RenaGum product infringes on its patent-in-suit, U.S. Patent Number 7,915,898, entitled “oral compositions for absorption of phosphorous compounds.” The gum uses chitosan to treat hypophosphatemia, or a phosphate deficiency, to help manage patients' renal disease.
Although Nestle didn't mention whether it or its subsidiary CM&D Pharma Ltd. are...
Already a subscriber? Click here to login